Optimizing Clinical Outcomes Utilizing Complement Mediators in Ophthalmic Indications: Are All Complement Pathways Equal?
Time: 2:30 pm
day: Conference Day Two
Details:
- Assess potential distinct roles for the Classical and Alternative Pathways in Age-Related Macular Degeneration (AMD)
- Describe the clinical outcomes with distinct complement approaches (Factor B, C3, C5, C1q)
- Debate the role of local versus systemic complement in AMD
